Prosight Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24M Sell
550,000
-720,273
-57% -$33.3M 4.66% 7
2026
Q2
$54.2M Buy
1,270,273
+474,726
+60% +$25.8M 9.34% 4
2026
Q1
$49.9M Buy
795,547
+585,547
+279% +$46.8M 8.19% 2
2025
Q4
$20M Buy
210,000
+133,900
+176% +$13.1M 4.14% 10
2025
Q3
$7.43M Buy
+76,100
New +$7.88M 1.73% 22

Other funds holding BSX

Prosight Management's BSX Position: Q3 2026 in Review

Prosight Management reduced its Boston Scientific (BSX) stake by 57% in Q3 2026, selling an estimated $33.3M and leaving 550,000 shares worth $24M. The position accounts for 4.66% of the portfolio, ranked #7.

Prosight Management first reported a position in BSX in Q3 2025 and has held it in 5 quarters since. The position peaked at $54.2M in Q2 2026. 1,512 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Prosight Management held 550,000 shares of Boston Scientific worth $24M as of Q3 2026.
  • Prosight Management sold 720,273 Boston Scientific shares in Q3 2026, an estimated $33.3M.
  • Boston Scientific made up 4.66% of Prosight Management's portfolio in Q3 2026, its #7 holding.
  • Prosight Management first reported a position in Boston Scientific in Q3 2025 and has held it in 5 quarters since.
  • Prosight Management's Boston Scientific position peaked at $54.2M in Q2 2026.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Prosight Management's 13F filing for Q3 2026, filed 13 Nov 2026.